Ribozyme mediated suppression of vascular endothelial growth factor gene expression enhances matrix metalloproteinase 1 expression in a human hepatocellular carcinoma cell line

Int J Oncol. 2002 Jul;21(1):81-4.

Abstract

The levels of expression of various genes were altered in cellular transformants with manipulation of expression of single genes. Vascular endothelial growth factor A (VEGF-A) is a key molecule for tumor progression, although it is unclear how VEGF-A expression regulates various genes. Multiple gene expression levels were evaluated using cDNA arrays in a human hepatocellular carcinoma cell line (HLF) with suppression of the VEGF-A gene by anti-VEGF-A ribozyme (alphaVRz). The ribozyme-mediated suppression of VEGF-A gene solely up-regulated matrix metalloproteinase 1 (MMP1) gene level in HLF/alphaVRz. Levels of expression of other members of MMP family or tissue inhibitors of MMPs did not show any alteration. These results suggested that intracellular suppression of VEGF-A gene was specifically linked to up-regulation of MMP1 in human hepatocellular carcinoma cells.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular / enzymology*
  • Carcinoma, Hepatocellular / genetics
  • Endothelial Growth Factors / antagonists & inhibitors
  • Endothelial Growth Factors / genetics*
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • Liver Neoplasms / enzymology*
  • Liver Neoplasms / genetics
  • Matrix Metalloproteinase 1 / genetics
  • Matrix Metalloproteinase 1 / metabolism*
  • Oligonucleotide Array Sequence Analysis
  • RNA, Catalytic / pharmacology*
  • Transformation, Genetic
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism
  • Up-Regulation
  • Vascular Endothelial Growth Factor A

Substances

  • Endothelial Growth Factors
  • RNA, Catalytic
  • Vascular Endothelial Growth Factor A
  • alpha VRz
  • Matrix Metalloproteinase 1